Nephrotoxic effects of varenicline as the most effective drug used for smoking cessation: a preliminary experimental study

Int Urol Nephrol. 2015 May;47(5):823-9. doi: 10.1007/s11255-015-0949-5. Epub 2015 Mar 27.

Abstract

Purpose: Varenicline is a new most effective drug for smoking cessation. Its effect on kidney functions remains unclear. This study purposed to investigate whether varenicline causes nephrotoxicity in rats.

Methods: Fifteen rats were randomly assigned to three groups: control, 0.0125 mg kg(-1) varenicline and 0.025 mg kg(-1) varenicline (single dose for 3 days, i.p.). Before and after experimental period, serum neutrophil gelatinase-associated lipocalin, creatinine and urea levels were measured. Total oxidant and antioxidant status were measured in kidney homogenates. Histological examination was performed in kidney.

Results: The nephrotoxic effects of varenicline were detected by histopathological and biochemical examinations in the varenicline treatment groups. No change was observed in the control group.

Conclusions: These findings firstly indicate that a 3-day varenicline treatment causes nephrotoxic effects in rats.

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / pathology*
  • Acute-Phase Proteins
  • Animals
  • Antioxidants / analysis
  • Creatinine / blood
  • Kidney / chemistry
  • Lipocalin-2
  • Lipocalins / blood
  • Male
  • Nicotinic Agonists / adverse effects*
  • Oxidants
  • Proto-Oncogene Proteins / blood
  • Rats
  • Rats, Wistar
  • Tobacco Use Cessation Devices / adverse effects*
  • Urea / blood
  • Varenicline / adverse effects*

Substances

  • Acute-Phase Proteins
  • Antioxidants
  • Lcn2 protein, rat
  • Lipocalin-2
  • Lipocalins
  • Nicotinic Agonists
  • Oxidants
  • Proto-Oncogene Proteins
  • Urea
  • Creatinine
  • Varenicline